Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Regulation of thymocyte trafficking by Tagap, a GAP domain protein linked to human autoimmunity.

Duke-Cohan JS, Ishikawa Y, Yoshizawa A, Choi YI, Lee CN, Acuto O, Kissler S, Reinherz EL.

Sci Signal. 2018 Jun 12;11(534). pii: eaan8799. doi: 10.1126/scisignal.aan8799.

PMID:
29895617
2.

Downregulation of semaphorin 3E promotes hallmarks of experimental chronic allergic asthma.

Movassagh H, Shan L, Duke-Cohan JS, Chakir J, Halayko AJ, Koussih L, Gounni AS.

Oncotarget. 2017 Oct 27;8(58):98953-98963. doi: 10.18632/oncotarget.22144. eCollection 2017 Nov 17.

3.

Semaphorin 3E Alleviates Hallmarks of House Dust Mite-Induced Allergic Airway Disease.

Movassagh H, Shan L, Duke-Cohan JS, Halayko AJ, Uzonna JE, Gounni AS.

Am J Pathol. 2017 Jul;187(7):1566-1576. doi: 10.1016/j.ajpath.2017.03.008.

PMID:
28634005
4.

Chemorepellent Semaphorin 3E Negatively Regulates Neutrophil Migration In Vitro and In Vivo.

Movassagh H, Saati A, Nandagopal S, Mohammed A, Tatari N, Shan L, Duke-Cohan JS, Fowke KR, Lin F, Gounni AS.

J Immunol. 2017 Feb 1;198(3):1023-1033. doi: 10.4049/jimmunol.1601093. Epub 2016 Dec 2.

5.

Pre-T Cell Receptors (Pre-TCRs) Leverage Vβ Complementarity Determining Regions (CDRs) and Hydrophobic Patch in Mechanosensing Thymic Self-ligands.

Das DK, Mallis RJ, Duke-Cohan JS, Hussey RE, Tetteh PW, Hilton M, Wagner G, Lang MJ, Reinherz EL.

J Biol Chem. 2016 Dec 2;291(49):25292-25305. Epub 2016 Oct 5.

6.

Pre-TCR ligand binding impacts thymocyte development before αβTCR expression.

Mallis RJ, Bai K, Arthanari H, Hussey RE, Handley M, Li Z, Chingozha L, Duke-Cohan JS, Lu H, Wang JH, Zhu C, Wagner G, Reinherz EL.

Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8373-8. doi: 10.1073/pnas.1504971112. Epub 2015 Jun 8.

7.

RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance.

Xiao Y, Yu S, Zhu B, Bedoret D, Bu X, Francisco LM, Hua P, Duke-Cohan JS, Umetsu DT, Sharpe AH, DeKruyff RH, Freeman GJ.

J Exp Med. 2014 May 5;211(5):943-59. doi: 10.1084/jem.20130790. Epub 2014 Apr 21.

8.

Dynamic control of β1 integrin adhesion by the plexinD1-sema3E axis.

Choi YI, Duke-Cohan JS, Chen W, Liu B, Rossy J, Tabarin T, Ju L, Gui J, Gaus K, Zhu C, Reinherz EL.

Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):379-84. doi: 10.1073/pnas.1314209111. Epub 2013 Dec 16.

9.

Plxnd1 expression in thymocytes regulates their intrathymic migration while that in thymic endothelium impacts medullary topology.

Choi YI, Duke-Cohan JS, Tan J, Gui J, Singh MK, Epstein JA, Reinherz EL.

Front Immunol. 2013 Nov 19;4:392. doi: 10.3389/fimmu.2013.00392. eCollection 2013.

10.

CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells.

Naito M, Hainz U, Burkhardt UE, Fu B, Ahove D, Stevenson KE, Rajasagi M, Zhu B, Alonso A, Witten E, Matsuoka K, Neuberg D, Duke-Cohan JS, Wu CJ, Freeman GJ.

Cancer Immunol Immunother. 2013 Feb;62(2):347-57. doi: 10.1007/s00262-012-1331-4. Epub 2012 Aug 25.

11.

A coprecipitation-based validation methodology for interactions identified using protein microarrays.

Marina O, Duke-Cohan JS, Wu CJ.

Methods Mol Biol. 2011;723:239-54. doi: 10.1007/978-1-61779-043-0_16.

PMID:
21370070
12.

Serologic markers of effective tumor immunity against chronic lymphocytic leukemia include nonmutated B-cell antigens.

Marina O, Hainz U, Biernacki MA, Zhang W, Cai A, Duke-Cohan JS, Liu F, Brusic V, Neuberg D, Kutok JL, Alyea EP, Canning CM, Soiffer RJ, Ritz J, Wu CJ.

Cancer Res. 2010 Feb 15;70(4):1344-55. doi: 10.1158/0008-5472.CAN-09-3143. Epub 2010 Feb 2.

13.

Ethnic differences and functional analysis of MET mutations in lung cancer.

Krishnaswamy S, Kanteti R, Duke-Cohan JS, Loganathan S, Liu W, Ma PC, Sattler M, Singleton PA, Ramnath N, Innocenti F, Nicolae DL, Ouyang Z, Liang J, Minna J, Kozloff MF, Ferguson MK, Natarajan V, Wang YC, Garcia JG, Vokes EE, Salgia R.

Clin Cancer Res. 2009 Sep 15;15(18):5714-23. doi: 10.1158/1078-0432.CCR-09-0070. Epub 2009 Sep 1.

14.

p85 Associates with unphosphorylated PTEN and the PTEN-associated complex.

Rabinovsky R, Pochanard P, McNear C, Brachmann SM, Duke-Cohan JS, Garraway LA, Sellers WR.

Mol Cell Biol. 2009 Oct;29(19):5377-88. doi: 10.1128/MCB.01649-08. Epub 2009 Jul 27.

15.

Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys.

Grandpre LE, Duke-Cohan JS, Ewald BA, Devoy C, Barouch DH, Letvin NL, Reinherz EL, Baden LR, Dolin R, Seaman MS.

Vaccine. 2009 Mar 4;27(10):1549-56. doi: 10.1016/j.vaccine.2009.01.010. Epub 2009 Jan 23.

16.

The heterogeneity of human antibody responses to vaccinia virus revealed through use of focused protein arrays.

Duke-Cohan JS, Wollenick K, Witten EA, Seaman MS, Baden LR, Dolin R, Reinherz EL.

Vaccine. 2009 Feb 18;27(8):1154-65. doi: 10.1016/j.vaccine.2008.12.035. Epub 2009 Jan 13.

17.

PlexinD1 glycoprotein controls migration of positively selected thymocytes into the medulla.

Choi YI, Duke-Cohan JS, Ahmed WB, Handley MA, Mann F, Epstein JA, Clayton LK, Reinherz EL.

Immunity. 2008 Dec 19;29(6):888-98. doi: 10.1016/j.immuni.2008.10.008. Epub 2008 Nov 27.

18.

Dipeptidyl peptidase-IV and related molecules: markers of malignancy?

Sedo A, Stremenová J, Bušek P, Duke-Cohan JS.

Expert Opin Med Diagn. 2008 Jun;2(6):677-89. doi: 10.1517/17530059.2.6.677.

PMID:
23495778
19.

Genetic fixity in the human major histocompatibility complex and block size diversity in the class I region including HLA-E.

Romero V, Larsen CE, Duke-Cohan JS, Fox EA, Romero T, Clavijo OP, Fici DA, Husain Z, Almeciga I, Alford DR, Awdeh ZL, Zuñiga J, El-Dahdah L, Alper CA, Yunis EJ.

BMC Genet. 2007 Apr 12;8:14.

20.

Juvenile-onset loss of lipid-raft domains in attractin-deficient mice.

Azouz A, Gunn TM, Duke-Cohan JS.

Exp Cell Res. 2007 Feb 15;313(4):761-71. Epub 2006 Dec 6.

PMID:
17196964
21.

Attractin is elevated in the cerebrospinal fluid of patients with malignant astrocytoma and mediates glioma cell migration.

Khwaja FW, Duke-Cohan JS, Brat DJ, Van Meir EG.

Clin Cancer Res. 2006 Nov 1;12(21):6331-6.

22.

Siva-1 negatively regulates NF-kappaB activity: effect on T-cell receptor-mediated activation-induced cell death (AICD).

Gudi R, Barkinge J, Hawkins S, Chu F, Manicassamy S, Sun Z, Duke-Cohan JS, Prasad KV.

Oncogene. 2006 Jun 8;25(24):3458-62. Epub 2006 Feb 20.

PMID:
16491128
23.

Regulation and function of SKAP-55 non-canonical motif binding to the SH3c domain of adhesion and degranulation-promoting adaptor protein.

Duke-Cohan JS, Kang H, Liu H, Rudd CE.

J Biol Chem. 2006 May 12;281(19):13743-50. Epub 2006 Feb 6.

24.

Dipeptidyl peptidase IV activity and/or structure homologs: contributing factors in the pathogenesis of rheumatoid arthritis?

Sedo A, Duke-Cohan JS, Balaziova E, Sedova LR.

Arthritis Res Ther. 2005;7(6):253-69. Epub 2005 Oct 26. Review.

25.

Neuronal plasticity after spinal cord injury: identification of a gene cluster driving neurite outgrowth.

Di Giovanni S, Faden AI, Yakovlev A, Duke-Cohan JS, Finn T, Thouin M, Knoblach S, De Biase A, Bregman BS, Hoffman EP.

FASEB J. 2005 Jan;19(1):153-4. Epub 2004 Nov 2.

PMID:
15522907
26.

Attractin: cautionary tales for therapeutic intervention in molecules with pleiotropic functionality.

Duke-Cohan JS, Kim JH, Azouz A.

J Environ Pathol Toxicol Oncol. 2004;23(1):1-11. Review.

PMID:
14994991
27.

Human secreted attractin disrupts neurite formation in differentiating cortical neural cells in vitro.

Tang W, Duke-Cohan JS.

J Neuropathol Exp Neurol. 2002 Sep;61(9):767-77.

PMID:
12230323
28.

Defective surface expression of attractin on T cells in patients with common variable immunodeficiency (CVID).

Pozzi N, Gaetaniello L, Martire B, De Mattia D, Balestrieri B, Cosentini E, Schlossman SF, Duke-Cohan JS, Pignata C.

Clin Exp Immunol. 2001 Jan;123(1):99-104.

29.

A biochemical function for attractin in agouti-induced pigmentation and obesity.

He L, Gunn TM, Bouley DM, Lu XY, Watson SJ, Schlossman SF, Duke-Cohan JS, Barsh GS.

Nat Genet. 2001 Jan;27(1):40-7.

PMID:
11137996
30.

Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells.

McAdam AJ, Chang TT, Lumelsky AE, Greenfield EA, Boussiotis VA, Duke-Cohan JS, Chernova T, Malenkovich N, Jabs C, Kuchroo VK, Ling V, Collins M, Sharpe AH, Freeman GJ.

J Immunol. 2000 Nov 1;165(9):5035-40.

31.

SH3 domain recognition of a proline-independent tyrosine-based RKxxYxxY motif in immune cell adaptor SKAP55.

Kang H, Freund C, Duke-Cohan JS, Musacchio A, Wagner G, Rudd CE.

EMBO J. 2000 Jun 15;19(12):2889-99.

32.

Attractin: a cub-family protease involved in T cell-monocyte/macrophage interactions.

Duke-Cohan JS, Tang W, Schlossman SF.

Adv Exp Med Biol. 2000;477:173-85. Review.

PMID:
10849745
33.

Secreted and membrane attractin result from alternative splicing of the human ATRN gene.

Tang W, Gunn TM, McLaughlin DF, Barsh GS, Schlossman SF, Duke-Cohan JS.

Proc Natl Acad Sci U S A. 2000 May 23;97(11):6025-30.

34.

The mouse mahogany locus encodes a transmembrane form of human attractin.

Gunn TM, Miller KA, He L, Hyman RW, Davis RW, Azarani A, Schlossman SF, Duke-Cohan JS, Barsh GS.

Nature. 1999 Mar 11;398(6723):152-6.

PMID:
10086356
35.

Attractin (DPPT-L), a member of the CUB family of cell adhesion and guidance proteins, is secreted by activated human T lymphocytes and modulates immune cell interactions.

Duke-Cohan JS, Gu J, McLaughlin DF, Xu Y, Freeman GJ, Schlossman SF.

Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11336-41.

36.

Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells.

Duke-Cohan JS, Morimoto C, Rocker JA, Schlossman SF.

J Immunol. 1996 Mar 1;156(5):1714-21.

PMID:
8596018
37.
38.

Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis.

Morimoto C, Lord CI, Zhang C, Duke-Cohan JS, Letvin NL, Schlossman SF.

Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9960-4.

39.

Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV.

Tanaka T, Duke-Cohan JS, Kameoka J, Yaron A, Lee I, Schlossman SF, Morimoto C.

Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3082-6.

40.

Phosphatidylinositol (PI) 3-kinase and PI 4-kinase binding to the CD4-p56lck complex: the p56lck SH3 domain binds to PI 3-kinase but not PI 4-kinase.

Prasad KV, Kapeller R, Janssen O, Repke H, Duke-Cohan JS, Cantley LC, Rudd CE.

Mol Cell Biol. 1993 Dec;13(12):7708-17.

41.
42.

Regulation of CD4-p56lck-associated phosphatidylinositol 3-kinase (PI 3-kinase) and phosphatidylinositol 4-kinase (PI 4-kinase).

Prasad KV, Kapeller R, Janssen O, Duke-Cohan JS, Repke H, Cantley LC, Rudd CE.

Philos Trans R Soc Lond B Biol Sci. 1993 Oct 29;342(1299):35-42.

PMID:
7904344
43.
44.

The reaction against autologous lymphoblasts as an indicator of lymphocyte hyperreactivity in rheumatoid arthritis.

Duke-Cohan JS, Rubinow A, Hirt R, Naor D.

Clin Immunol Immunopathol. 1990 Feb;54(2):298-308.

PMID:
1967232
45.

Use of an autologous reaction in vitro to assess contributions of T and B lymphocytes to immune hyperreactivity of atopics.

Duke-Cohan JS, Hirt R, Rottem M, Ben-Zvi A, Rubinow A, Naor D.

Clin Exp Allergy. 1989 Mar;19(2):163-8.

PMID:
2787692
46.
47.
48.

Observations on the seeding of hematopoietic stem cells. Selective development in the transplanted recipient.

Duke-Cohan JS, Davies AJ.

Transplantation. 1987 Apr;43(4):600-2. No abstract available. Erratum in: Transplantation 1987 Oct;44(4):591.

PMID:
2883746
49.
50.

Supplemental Content

Loading ...
Support Center